MedTrace Logo

Bacterial Load for Integra™ in Operative Wounds

NCT04543240 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2020-09-11

No results posted yet for this study

Summary

Proportion of postoperative complications (infections, dehiscence, graft slough) after initial application of Integra™

Conditions

  • Wounds and Injuries

Interventions

DEVICE

Integra™ dermal regeneration template

Integra a biologic dressing for deep wounds or large soft tissue defects that penetrate to the level of bone

Sponsors & Collaborators

  • Integra LifeSciences Corporation

    collaborator INDUSTRY

  • Georgetown University

    lead OTHER

Principal Investigators

  • Christopher Attinger, MD · MedStar Georgetown University Hopsital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-14
Primary Completion
2021-01-01
Completion
2021-01-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04543240 on ClinicalTrials.gov